Inflexion, a leading European mid-market private equity firm, is pleased to announce that it has been named Best Pan-European Mid-Market LBO Fund at the 2024 Private Equity Exchange Awards. This marks the first time Inflexion has secured a win in the European category, following two previous wins in the UK category. The achievement underscores Inflexion’s successful European expansion, highlighted by the opening of three offices on the continent in the past five years. Current European investments include Finanzen, Tierarzt Plus Partner, Village Vets, Nomentia, DSS+, YER, Proteros, Infront, SteriPack, Enviolo, European LifeCare and Calco. 

During the judging period, Inflexion announced eleven exits, including the highly successful sales of Automative Transformation Group, Chambers and Partners, DR&P and Lintbells, generating over £1.3bn in proceeds and delivering a gross return of 3.3x. The firm also invested £1.8bn into fifteen new investments across Europe and supported 79 acquisitions for its portfolio across 15 countries globally. The portfolio achieved c.20% EBITDA growth.

Alongside this, Inflexion successfully closed Partnership Capital Fund III at its hard cap of £1.75bn in March 2024, making it the largest dedicated minority fund in Europe. In September 2024, we successfully closed Enterprise Fund VI at its hard cap of £975m, more than doubling its £400m predecessor.

Inflexion continued to expand its international footprint to support its portfolio and reflect the growing opportunity in the European mid-market. New offices in Frankfurt and Stockholm follow the successful launch of an Amsterdam office. In the last 18 months, across the UK and European offices, Inflexion has increased its FTE count by 56.